Cure for certain cancers is ‘realistic’ goal in next decade, pharma lead says

Jun 17, 2026, 10:11 PM

Johnson & Johnson CEO cites immunotherapy breakthroughs in multiple myeloma, remission rates and longevity...

Redirecting to full article...